HCP|NETWORK.
Sign In
Please enter a keyword or adjust filters to filter the search.
Medical News
27th Nov, 2025
phys.org
The presence of robots in schools is no longer surprising. How do elementary school children treat humanoid robots? Are they polite to them, and willing to attribute human-like qualities to them? Researchers from SWPS University have shown that in most cases, children treat robots politely, and younger children and girls are more likely to perceive them as possessing human-like qualities.
Hybrid materials made of magnets and superconductors give rise to fascinating quantum phenomena, which are so sensitive that it is crucial to measure them with minimal interference. Researchers at the University of Hamburg and the University of Illinois Chicago have now demonstrated, both experimentally and theoretically, how these quantum phenomena can be detected and controlled over longer distances using special techniques with a scanning tunneling microscope.
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct. 30, hosted by the Abdul Latif Jameel Clinic for Machine Learning in Health (MIT Jameel Clinic). Headlining the event was MIT Ph.D. student and BoltzGen's first author Hannes Stärk, who had announced BoltzGen just a few days prior.
Persistent organic pollutants (POPs) begin to accumulate in the tissues of mammals already during the fetal stage, according to new research from the University of Oulu, Finland. The animal-model study found that environmental toxins had built up in the tissues of sheep raised in clean organic production, and that the same substances were transferred in notable amounts to the developing fetuses' adipose tissue.
A comprehensive study by the CritMET research group, led by Prof. Michael Bau, a geochemist at Constructor University in Bremen, provides evidence of widespread contamination of the North Sea and the Baltic Sea with MRI contrast agents. As modern wastewater treatment plants cannot remove these contaminants from the wastewater, they can freely enter the environment and pollute rivers and lakes. Recently published research from a Bremen area group has shown that rare earth elements directly attributed to MRIs are now present in the North and the Baltic seas.
Shallow seas serve as critical transition zones connecting land and the deep ocean, supplying essential resources for navigation, fisheries, energy exploration, and island reef development. Accurate bathymetric data form the foundation for marine engineering, channel safety, resource assessment, and ecological restoration. However, nearly 50% of global shallow-water areas still lack reliable depth information, creating a major barrier to coastal management and sustainable ocean development.
As climate change and the resulting extreme weather intensify, interest in weather modification is growing around the world. In Japan, under Goal 8 of the Moonshot Research and Development Program led by the Cabinet Office / JST (Japan Science and Technology Agency), a research and development program for weather control has been launched to mitigate extreme wind and water damage.
HIV
The Lancet
Globally, in 2024, 87% of all people living with HIV knew their HIV status, and among people aware of their status and on treatment, 94% were virally suppressed. As progress is being made to reach the UNAIDS 95-95-95 targets, one of the key public health challenges for HIV lies in optimising continuity of care and effectively re-engaging people out of care. Across settings, up to 40–50% of individuals diagnosed with HIV are disengaged from HIV care. Delaying or discontinuing HIV treatment can negatively affect health outcomes at the individual level, including increasing viraemia and mortality, and increases the risk for ongoing HIV transmission at the community level.
2nd Dec, 2025
People with HIV experience higher burden of cardiometabolic, mood, and cognitive disorders. Poor-quality and insufficient sleep are both associated with increased risk for these comorbidities and are more common in people with HIV. Although previous reviews have explored the prevalence and risk factors for sleep complaints in people with HIV, few have differentiated these complaints by potential underlying causes. Disordered sleep in people with HIV might arise from HIV-specific sleep disruptors, including direct effects of the virus, chronic inflammation, and antiretroviral treatment.
High rates of viral suppression in response to tenofovir–lamivudine–dolutegravir therapy in individuals who had suppression before switching support international treatment guidelines for this population. Findings on resistance mutations and tenofovir diphosphate concentrations suggest that incomplete adherence was a key factor in the suboptimal outcomes of people with virological failure at the time of switching treatment.
People have multiple identities, but this fact can be overshadowed by the diagnosis of a disease. Formed in 1991 by the late Sivananda Khan, an HIV and gay rights activist, the Naz Project London (Naz) realised that people living with HIV in South Asian communities needed support encompassing their multiple identities of faith, sexuality, gender identity, and ethnicity. “So those four core intersections were our starting point. That's why we existed, because we recognised people who were coming to Naz were not presenting single-issue stories or one-dimensional identities.
Ellis J, Groppelli E, Doyle R, et al. Epstein–Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial. Lancet HIV 2025; 12: e691–700—In table 3 of this Article, the fourth and fifth row subheadings should have read “Low-level cytomegalovirus viraemia (<1000 copies per mL)” and “High-level cytomegalovirus viraemia (≥1000 copies per mL)”.
Gökengin D. Outcomes and gaps in HIV care for migrants in Europe. Lancet HIV 2024; 11: e793–94—In the fourth sentence of the third paragraph of this Comment, the percentage for the risk of virological failure among migrants changed to 93% during corrections to the original research on which this Comment was based. This correction has been made as of Oct 6, 2025.
Ryan P, Blanco JL, Masia M, et al. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV 2025; 12: e473–84—In this Article in the third sentence of paragraph four of the Results, mean adjusted weight change from baseline should have been 1·81 kg (95% CI 1·28–2·34) in the bictegravir group. This correction has been made as of Sept 25, 2025.
Ratevosian J, Reid M, Ni Z, et al. Reimagining HIV prevention with artificial intelligence. Lancet HIV 2025; published online June 11. https://doi.org/10.1016/S2352-3018(25)00158-4—In this Comment, a reference to use of artificial intelligence in a Nigerian pre-exposure prophylaxis programme was incorrect, and the text and references have been updated. This correction has been made as of Sept 5, 2025.
15th Jan, 2026
Cardiology
Journal of the American Medical Association
Medical Journal
Wiley
Regional Health – Southeast Asia
